After Altice Labs and the Champalimaud Foundation (FC) made history with the first breast cancer surgery using 5G technology, which united Portugal and Spain, it is now MEO Empresas 's turn to join the FC and materialize its desire to add value to the health area by creating a standardized system for interoperability and cloud storage of patient clinical data, duly anonymized and secure.
While at this stage the data is intended for researchers who want to study it, in the future the aim is to make it available to clinicians and patients themselves, to be consulted via the internet anywhere in the world.
This infrastructure, optimised and customised for the Champalimaud Foundation's Breast Unit, offers a range of benefits and added value to medicine, and is another important step forward in this area:
- Sharing data with and between researchers opens up a window of opportunity for artificial intelligence research in the field of health;
- Accelerating clinical studies that facilitate the implementation of these new technologies at the service of patients and doctors;
- To encourage the discovery of new experiences and new areas where technology and medicine intersect, in a new ecosystem that guarantees the creation of a new branch of medicine for a new era of Personalisation of treatment through precision medicine.
This concept aims to make space and relevance for technology and applications in this innovative health ecosystem to combat chronic diseases such as diabetes and cancer, whether through 5G infrastructures and technologies, Virtual and Augmented Reality, Cloud, Big Data and Artificial Intelligence with a view to building the Operating Room of the Future.
Today, as on the first day, MEO Empresas 's challenge remains the same: to prepare companies to reach their true potential, generate greater value and create a more positive impact on the market and the world.